November 2015 Tucson critical care journal club: atrial fibrillation in sepsis

No abstract available. Article truncated at 150 words. Sepsis is a major public health concern in the United States (1). Nearly one-third of in-hospital deaths are the result of sepsis (2). Atrial fibrillation (A-fib) is the most common arrhythmia in sepsis and its development portends worse outcome...

Full description

Bibliographic Details
Main Authors: Nahapetian RR, Gerald J
Format: Article
Language:English
Published: Arizona Thoracic Society 2015-12-01
Series:Southwest Journal of Pulmonary and Critical Care
Subjects:
Online Access:http://www.swjpcc.com/critical-care-journal-club/2015/12/11/november-2015-tucson-critical-care-journal-club-atrial-fibri.html
id doaj-3a8e9750360b4b5d808f7ebebfac6d73
record_format Article
spelling doaj-3a8e9750360b4b5d808f7ebebfac6d732020-11-24T21:15:59ZengArizona Thoracic SocietySouthwest Journal of Pulmonary and Critical Care2160-67732015-12-0111626626810.13175/swjpcc148-15November 2015 Tucson critical care journal club: atrial fibrillation in sepsisNahapetian RR 0Gerald J1University of Arizona, Tucson, AZ USAUniversity of Arizona, Tucson, AZ USANo abstract available. Article truncated at 150 words. Sepsis is a major public health concern in the United States (1). Nearly one-third of in-hospital deaths are the result of sepsis (2). Atrial fibrillation (A-fib) is the most common arrhythmia in sepsis and its development portends worse outcomes (3). Current guidelines recommend cardioversion in hemodynamically unstable patients with sepsis; however, there is scant evidence to guide the choice between amiodarone, beta-blockers, calcium-channel blockers, and digoxin (4). In patients with decompensated heart failure, digoxin and amiodarone are preferred over beta-blockers and calcium channel blockers (4). In patients with multiple organ failure there is no evidence to suggest any one agent is superior to the others. This study by Walkey et al. sought to identify current practice patterns in the pharmacologic treatment of A-fib among hospitalized patients with sepsis and to compare outcomes after controlling for potential confounding variables. This retrospective cohort study used a nationally representative source of hospital billing ... http://www.swjpcc.com/critical-care-journal-club/2015/12/11/november-2015-tucson-critical-care-journal-club-atrial-fibri.htmlsepsisatrial fibrillationbeta blockerbeta blockerscalcium channel blockerdigoxinamiodaronemortalityoutcomesobservational
collection DOAJ
language English
format Article
sources DOAJ
author Nahapetian RR
Gerald J
spellingShingle Nahapetian RR
Gerald J
November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
Southwest Journal of Pulmonary and Critical Care
sepsis
atrial fibrillation
beta blocker
beta blockers
calcium channel blocker
digoxin
amiodarone
mortality
outcomes
observational
author_facet Nahapetian RR
Gerald J
author_sort Nahapetian RR
title November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
title_short November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
title_full November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
title_fullStr November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
title_full_unstemmed November 2015 Tucson critical care journal club: atrial fibrillation in sepsis
title_sort november 2015 tucson critical care journal club: atrial fibrillation in sepsis
publisher Arizona Thoracic Society
series Southwest Journal of Pulmonary and Critical Care
issn 2160-6773
publishDate 2015-12-01
description No abstract available. Article truncated at 150 words. Sepsis is a major public health concern in the United States (1). Nearly one-third of in-hospital deaths are the result of sepsis (2). Atrial fibrillation (A-fib) is the most common arrhythmia in sepsis and its development portends worse outcomes (3). Current guidelines recommend cardioversion in hemodynamically unstable patients with sepsis; however, there is scant evidence to guide the choice between amiodarone, beta-blockers, calcium-channel blockers, and digoxin (4). In patients with decompensated heart failure, digoxin and amiodarone are preferred over beta-blockers and calcium channel blockers (4). In patients with multiple organ failure there is no evidence to suggest any one agent is superior to the others. This study by Walkey et al. sought to identify current practice patterns in the pharmacologic treatment of A-fib among hospitalized patients with sepsis and to compare outcomes after controlling for potential confounding variables. This retrospective cohort study used a nationally representative source of hospital billing ...
topic sepsis
atrial fibrillation
beta blocker
beta blockers
calcium channel blocker
digoxin
amiodarone
mortality
outcomes
observational
url http://www.swjpcc.com/critical-care-journal-club/2015/12/11/november-2015-tucson-critical-care-journal-club-atrial-fibri.html
work_keys_str_mv AT nahapetianrr november2015tucsoncriticalcarejournalclubatrialfibrillationinsepsis
AT geraldj november2015tucsoncriticalcarejournalclubatrialfibrillationinsepsis
_version_ 1716743836401664000